News | October 15, 2021
Shilpa Medicare raises over Rs. 297 crore through preferential allotment
Equity raise to finance growth and investments in the biological space
Equity raise to finance growth and investments in the biological space
Harvard Medical School will deliver the first customized program, ‘Accelerate’, to create the next generation of leading experts in clinical development and medical affairs
In Western Europe, about 2% of procedures are done robotically while the majority, approximately 65%, are open surgery
Alnylam is the latest partner in the Medicines Manufacturing Innovation Centre’s third Grand Challenge project, which aims to revolutionise the manufacturing process for oligonucleotide therapies
The transaction is anticipated to close in the first quarter of 2022
The company's sustainability programme was evaluated on its policies, actions put in place to support objectives and targets, as well as results that were generated from the programme
Ectosense’s NightOwl is a leading cloud-connected home sleep apnea test
The consideration for the medicines in India is valued at Rs 180.48 crore
The listings aim to address global health priorities, identifying the medicines that provide the greatest benefits, and which should be available and affordable for all
The CAC solution cleared by the U.S. FDA analyses already existing non-gated CT scans and quantifies the coronary artery calcium in order to identify, stratify, and facilitate treatment pathways for patients with cardiovascular disease
Subscribe To Our Newsletter & Stay Updated
